piperidine has been researched along with Acute Confusional Senile Dementia in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhardwaj, M; Grover, P; Malhotra, A; Mehta, L; Rohilla, S | 1 |
| Bajda, M; Godyń, J; Hagenow, S; Kieć-Kononowicz, K; Kuder, K; Malawska, B; Stark, H; Stawarska, E; Zaręba, P; Łątka, K; Łażewska, D | 1 |
| Calò, S; Cardoso, SM; Chaves, S; Gwizdala, K; Magalhães, JD; Piemontese, L; Queda, F; Santos, MA | 1 |
| Chowdhury, SR; Fu, L; Gu, J; Hu, Y; Jiang, F; Lam, C; Lei, S; Lu, D; Tavallaie, MS; Wang, J | 1 |
| Alptuzun, V; Erciyas, E; Holzgrabe, U; Karadagli, SS; Parlar, S; Sayar, G; Tarikogullari, AH | 1 |
| Fu, Y; Hu, Y; Lu, D; Shi, Z; Xing, W; Zhang, H | 1 |
| Gogineni, A; Hanson, JE; Herrington, J; Meilandt, WJ; Reynen, P; Scearce-Levie, K; Weimer, RM; Zhou, Q | 1 |
| Hussain, I; Hussein, HA; Najafian, FT; Nugent, TC | 1 |
| Arce, MP; Conde, S; García, AG; González-Muñoz, GC; López, B; López, MG; Pérez, C; Rodríguez-Franco, MI; Villarroya, M | 1 |
| Chae, BS; Eun, JS; Kim, DK; Kim, KH; Kwon, YE; Lee, SK; Leem, JY; No, KT; Park, JY; Shin, JH; Shin, TY; Yang, JH | 1 |
1 review(s) available for piperidine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Piperidine Nucleus as a Promising Scaffold for Alzheimer's Disease: Current Landscape and Future Perspective.
Topics: Alzheimer Disease; Humans; Neurodegenerative Diseases; Piperidines; Structure-Activity Relationship | 2023 |
9 other study(ies) available for piperidine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Search for new multi-target compounds against Alzheimer's disease among histamine H
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Benzopyrans; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Electrophorus; Histamine H3 Antagonists; Horses; Humans; Ligands; Molecular Docking Simulation; Molecular Structure; Neuroprotective Agents; Piperidines; Receptors, Histamine H3; Structure-Activity Relationship | 2020 |
Novel Donepezil-Arylsulfonamide Hybrids as Multitarget-Directed Ligands for Potential Treatment of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Cell Line, Tumor; Cholinesterase Inhibitors; Donepezil; Humans; Ligands; Piperazines; Piperidines; Structure-Activity Relationship; Sulfonamides | 2021 |
Synthesis, biological evaluation and molecular modeling of benzofuran piperidine derivatives as Aβ antiaggregant.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Benzofurans; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Neuroprotective Agents; Piperidines; Protein Aggregates; Protein Aggregation, Pathological; Structure-Activity Relationship | 2021 |
Synthesis, bioactivity and molecular modeling studies on potential anti-Alzheimer piperidinehydrazide-hydrazones.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Benzothiazoles; Biphenyl Compounds; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Electrophorus; Horses; Humans; Hydrazones; Models, Molecular; Molecular Structure; Neuroprotective Agents; Picrates; Piperidines; Structure-Activity Relationship; Sulfonic Acids | 2019 |
Discovery of novel 2,6-disubstituted pyridazinone derivatives as acetylcholinesterase inhibitors.
Topics: Acetylcholinesterase; Alzheimer Disease; Binding, Competitive; Biocatalysis; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Drug Discovery; Humans; Models, Molecular; Molecular Structure; Piperidines; Protein Binding; Protein Structure, Tertiary; Pyridazines; Structure-Activity Relationship | 2013 |
Chronic GluN2B antagonism disrupts behavior in wild-type mice without protecting against synapse loss or memory impairment in Alzheimer's disease mouse models.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Attention Deficit and Disruptive Behavior Disorders; Behavior, Animal; Disease Models, Animal; Female; HEK293 Cells; Humans; In Vitro Techniques; Male; Maze Learning; Membrane Potentials; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Piperidines; Synapses | 2014 |
Beyond Chemoselectivity: Catalytic Site-Selective Aldolization of Diketones and Exploitation for Enantioselective Alzheimer's Drug Candidate Synthesis.
Topics: Aldehydes; Alzheimer Disease; Amyloid Precursor Protein Secretases; Chemistry Techniques, Synthetic; Drug Discovery; Humans; Ketones; Piperidines; Stereoisomerism | 2016 |
Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Catalytic Domain; Cattle; Cell Death; Cell Line, Tumor; Cell Survival; Cholinergic Agents; Cholinesterase Inhibitors; Esters; Glutamic Acid; Humans; Hydrophobic and Hydrophilic Interactions; Neuroprotective Agents; Permeability; Piperidines; Protein Binding | 2009 |
Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Butyrylcholinesterase; Cell Line; Cell Survival; Cholinesterase Inhibitors; Donepezil; Humans; Indans; Models, Molecular; Molecular Structure; Peptide Fragments; Piperidines; Protein Structure, Tertiary; Structure-Activity Relationship | 2007 |